Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Darbepoetin-alpha and i.v. Iron Administration After Autologous Hematopoietic Stem Cell Transplantation : a Prospective Randomized Trial

NCT00557817 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT00557817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00557817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Darbepoetin-alpha and i.v. Iron Administration After Autologous Hematopoietic Stem Cell Transplantation : a Prospective Randomized Trial
Lead sponsor
University of Liege
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2004
Completion date
August 31, 2008
Enrollment
125 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies